RXST
RxSight, Inc.
Key Financials
Operating Income
$-48191000
↓ 30.7%
Net Income
$-38944000
↓ 41.8%
Gross Profit
$103.0M
↑ 4.1%
Revenue
$134.5M
↓ 3.9%
EPS (Diluted)
$-0.95
↓ 33.8%
Cash & Equivalents
$19.9M
↑ 19.4%
Total Liabilities
$36.1M
↓ 3.2%
Total Assets
$311.8M
↓ 2.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/16/2026 | View on SEC |
| SD | 5/29/2026 | View on SEC |
| SCHEDULE 13G/A | 5/13/2026 | View on SEC |
| 10-Q | 5/6/2026 | View on SEC |
| 8-K | 5/6/2026 | View on SEC |
| ARS | 4/28/2026 | View on SEC |
| DEFA14A | 4/28/2026 | View on SEC |
| DEF 14A | 4/28/2026 | View on SEC |
| 4 | 4/20/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RXST |
| Company Name | RxSight, Inc. |
| CIK | 1111485 |
| Sector | Ophthalmic Goods |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3851 |
| SIC Description | Ophthalmic Goods |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 949-521-7822 |